BV
Bhaskar Vemban Iyer
About Bhaskar Vemban Iyer
Data last updated:
Bhaskar Vemban Iyer is a Director at Corona Remedies Limited (since 2025), Director at Rpg Life Sciences Limited (since 2019) and Director at Themis Medicare Limited (since 2021). The companies operate in Pharma and Healthcare. The 3 current companies with reported revenue have a combined latest revenue of ₹2,279 Cr; the largest is Corona Remedies Limited at ₹1,202 Cr (FY 2025). Earlier, Bhaskar Vemban Iyer was a Director at Bharat Serums And Vaccines Limited (2021–2024) and Director at Astrazeneca Pharma India Limited (2004–2010) and 6 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Corona Remedies Limited L24231GJ2004PLC044656 | Director | 04 Jan 2025 | 2004 | ₹1,202 Cr (FY 2025) | Active |
 Rpg Life Sciences Limited L24232MH2007PLC169354 | Director | 30 Oct 2019 | 2007 | ₹666 Cr (FY 2025) | Active |
 Themis Medicare Limited L24110GJ1969PLC001590 | Director | 12 Nov 2021 | 1969 | ₹410 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Bharat Serums And Vaccines Limited U74110MH1993PLC075088 | Director | 22 Sep 2021 | 1993 | ₹1,557 Cr (FY 2026) | Active |
 Astrazeneca Pharma India Limited L24231KA1979PLC003563 | Director | 06 May 2004 | 1979 | ₹1,757 Cr (FY 2025) | Active |
 Abbott India Limited L24239MH1944PLC007330 | Director | 20 Feb 2013 | 1944 | ₹6,685 Cr (FY 2025) | Active |
 Pharmarack Technologies Private Limited U72900PN2015PTC156535 | Director | 19 Mar 2019 | 2015 | ₹45.34 Cr (FY 2024) | Active |
 Ra Chem Pharma Limited U24110TG1996PLC022816 | Director | 27 Oct 2020 | 1996 | ₹621 Cr (FY 2021) | Amalgamated |
 Zcl Chemicals Limited U24100MH1991PLC060748 | Director | 09 Mar 2021 | 1991 | ₹418 Cr (FY 2023) | Amalgamated |
 Bharat Serums And Vaccines Limited U24230MH1971PLC015134 | Director | 07 Feb 2020 | 1971 | ₹1,455 Cr (FY 2023) | Amalgamated |
 Cohance Lifesciences Limited U24100MH2020PLC402958 | Director | 27 Oct 2022 | 2020 | ₹1,362 Cr (FY 2024) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Bhaskar Vemban Iyer
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Bhaskar Vemban Iyer
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bhaskar Vemban Iyer
Bhaskar Vemban Iyer currently holds 3 directorships: Corona Remedies Limited (Director, since 04 Jan 2025, revenue ₹1,202 Cr (FY 2025)); Rpg Life Sciences Limited (Director, since 30 Oct 2019, revenue ₹666 Cr (FY 2025)); Themis Medicare Limited (Director, since 12 Nov 2021, revenue ₹410 Cr (FY 2025)).
Bhaskar Vemban Iyer was first appointed on 06 May 2004 as Director at Astrazeneca Pharma India Limited. The most recent appointment on record is 04 Jan 2025 at Corona Remedies Limited.
The 3 current companies of Bhaskar Vemban Iyer that report revenue have a combined latest revenue of ₹2,279 Cr: Corona Remedies Limited ₹1,202 Cr (FY 2025); Rpg Life Sciences Limited ₹666 Cr (FY 2025); Themis Medicare Limited ₹410 Cr (FY 2025).
Bhaskar Vemban Iyer held 8 earlier board appointments: Bharat Serums And Vaccines Limited (Director, 22 Sep 2021 to 23 Oct 2024); Astrazeneca Pharma India Limited (Director, 06 May 2004 to 23 Feb 2010); Abbott India Limited (Director, 20 Feb 2013 to 31 Mar 2018); Pharmarack Technologies Private Limited (Director, 19 Mar 2019 to 05 Apr 2021); Ra Chem Pharma Limited (Director, from 27 Oct 2020); and 3 more.
The current boards of Bhaskar Vemban Iyer's companies include Ameetkumar Hiranyakumar Desai (Corona Remedies Limited), Ankur Kirtikumar Mehta (Corona Remedies Limited), Bhavin Nareshbhai Bhagat (Corona Remedies Limited), Chetna Prabhatkumar Dharajiya (Corona Remedies Limited), Kirtikumar Laxmidas Mehta (Corona Remedies Limited), Monica Hemal Kanuga (Corona Remedies Limited), among others.